Please use this identifier to cite or link to this item: http://hdl.handle.net/2445/187068
Full metadata record
DC FieldValueLanguage
dc.contributor.authorBonanad, Clara-
dc.contributor.authorEsteve Claramunt, Francisca-
dc.contributor.authorGarcía Blas, Sergio-
dc.contributor.authorAyesta, Ana-
dc.contributor.authorDíez Villanueva, Pablo-
dc.contributor.authorPérez Rivera, Jose Ángel-
dc.contributor.authorFerreiro, José Luis-
dc.contributor.authorCánoves, Joaquim-
dc.contributor.authorLópez Fornás, Francisco-
dc.contributor.authorAriza Solé, Albert-
dc.contributor.authorRaposerias, Sergio-
dc.contributor.authorVivas, David-
dc.contributor.authorBlanco, Regina-
dc.contributor.authorBompart Berroterán, Daznia-
dc.contributor.authorCordero, Alberto-
dc.contributor.authorNúñez, Julio-
dc.contributor.authorFácila, Lorenzo-
dc.contributor.authorNúñez Gil, Iván J.-
dc.contributor.authorGórriz, José Luis-
dc.contributor.authorBodi, Vicente-
dc.contributor.authorMartínez Selles, Manuel-
dc.contributor.authorRuiz Nodar, Juan Miguel-
dc.contributor.authorChorro, Francisco Javier-
dc.date.accessioned2022-06-27T11:01:55Z-
dc.date.available2022-06-27T11:01:55Z-
dc.date.issued2022-05-26-
dc.identifier.issn2077-0383-
dc.identifier.urihttp://hdl.handle.net/2445/187068-
dc.description.abstractThe treatment of acute coronary syndrome (ACS) in elderly patients continues to be a challenge because of the characteS.G.B.ristics of this population and the lack of data and specific recommendations. This review summarizes the current evidence about critical points of oral antithrombotic therapy in elderly patients. To this end, we discuss the peculiarities and differences reported referring to dual antiplatelet therapy (DAPT) in ACS management in elderly patients and what might be the best option considering these population characteristics. Furthermore, we analyze antithrombotic strategies in patients with atrial fibrillation (AF), with a particular focus on those cases that also present coronary artery disease (CAD). It is imperative to deepen our knowledge regarding the management of these challenging patients through real-world data and specifically designed geriatric studies to help resolve the questions remaining in their disease management.-
dc.format.extent15 p.-
dc.format.mimetypeapplication/pdf-
dc.language.isoeng-
dc.publisherMDPI-
dc.relation.isformatofReproducció del document publicat a: https://doi.org/10.3390/jcm11113008-
dc.relation.ispartofJournal of Clinical Medicine, 2022, vol. 11, num. 11-
dc.relation.urihttps://doi.org/10.3390/jcm11113008-
dc.rightscc by (c) Bonanad, Clara et al, 2022-
dc.rights.urihttp://creativecommons.org/licenses/by/3.0/es/*
dc.sourceArticles publicats en revistes (Institut d'lnvestigació Biomèdica de Bellvitge (IDIBELL))-
dc.subject.classificationMalalties del cor-
dc.subject.classificationAnticoagulants (Medicina)-
dc.subject.otherHeart diseases-
dc.subject.otherAnticoagulants (Medicine)-
dc.titleAntithrombotic Therapy in Elderly Patients with Acute Coronary Syndromes-
dc.typeinfo:eu-repo/semantics/article-
dc.typeinfo:eu-repo/semantics/publishedVersion-
dc.date.updated2022-06-27T10:00:12Z-
dc.rights.accessRightsinfo:eu-repo/semantics/openAccess-
dc.identifier.pmid35683397-
Appears in Collections:Articles publicats en revistes (Institut d'lnvestigació Biomèdica de Bellvitge (IDIBELL))

Files in This Item:
File Description SizeFormat 
jcm-11-03008.pdf331.09 kBAdobe PDFView/Open


This item is licensed under a Creative Commons License Creative Commons